Biotia
Health Care
$17Mtotal raised · 2 rounds on record
$9Mlatest round · Venture round · Oct 2026 · 1 mo ago
4backers · DigitalDx Ventures, Hyperplane
12stories in the press
Overview
Biotia is advancing infectious disease diagnostics for patients managing challenging infections. Learn more about our work.
Funding and backers
Total raised
$17M
2 rounds on record
Latest round
$9M
Venture round · Oct 2026 · 1 mo ago
Backers
4
DigitalDx Ventures, Hyperplane
The money's age
Fresh money
1 months since the last round · not hiring
Momentum
35/100
in the news, fresh money
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 1
Raised a round Venture round $9M · PR Newswire
May 19
Launched Biotia Launches Clinically Approved Drug Resistance Reporting for Complicated UTIs, Backed by Second Consecutive CAMDA Win · PRNewswire
Sep 1, 2025
Partnership Biotia and Hospital for Special Surgery Announce Collaboration to Advance Diagnostics for Prosthetic Joint Infections · businesswire.com
Aug 23, 2022
Raised a round Series A $8M · FinanzNachrichten.de
Tractionpublic signals, read monthly
Web presence
top 0.77%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Oct 2026 | $9M | — | PR Newswire |
| Series A | Aug 2022 | $8M | — | FinanzNachrichten.de |
Backed byfrom the funds' portfolios and accelerator catalogs
DigitalDx Ventures 
Hyperplane 
OCA Ventures 
TAU Ventures Investors in similar startupsfunds that back the companies most like this one
backs Delve Bio, SpyBiotech
backs virion
Similar startupsby what they do, their industry and backers
T cell Based Immunotherapies for Cancer and Chronic Infectious Diseases.
Discover P95 full-service CRO clinical trial solutions. Experts in epidemiology and real-world evidence for vaccines and infectious…
Savics offers digital solutions for health actors to improve their data management, disease diagnostics and GeneXpert connectivity.
Avelo’s mission is to save lives by bringing fast and actionable infectious disease diagnostics closer to the patient. Our solution is a…
Discover diagnostic solutions from SSI Diagnostica Group for infectious diseases, vaccine quality control, and microbiology laboratories.
Paratek Pharmaceuticals is committed to developing and delivering innovative treatments for serious infectious diseases. Learn about our…
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Show all 4 Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Biotia Raises $9M to Close the Diagnostic Gap for Recurrent and Culture-Negative UTIs
As many as 1 in 3 urine cultures come back negative, yet the burning and urgency keep coming. A Cornell Tech spinout says the infection is often still there: in a study of 200+ culture-negative samples, its sequencing test found a pathogen in 63% of them.
Read more
Report
Biotia Raises New Oversubscribed $9M Financing and Expands Board to Scale Infectious Disease Diagnostics in Women's Health and Orthopedics
NEW YORK, Oct. 1, 2026 /PRNewswire/ -- Biotia, the clinical metagenomics company whose BIOTIA-ID Urine Test identifies the cause of recurrent and complicated urinary tract infections (UTIs) with 97% sensitivity and 99% specificity, today announced an over
Read more
Report
Biotia Launches Clinically Approved Drug Resistance Reporting for Complicated UTIs, Backed by Second Consecutive CAMDA Win
/PRNewswire/ -- Biotia, a company advancing infectious disease diagnostics for challenging infections, today announced the clinical deployment of its...
Read more
Report
Report
Biotia Announces Advanced "Test to Treat" Offering for Recurrent Urinary Tract Infections
Biotia today announced the launch of a new "test to treat" option for patients suffering from recurrent urinary tract infections (UTIs), moving UTI care forward. This solution allows patients to collect a urine sample for more advanced laboratory testing,
Read more
Report
Biotia and Hospital for Special Surgery Announce Collaboration to Advance Diagnostics for Prosthetic Joint Infections
Read more
Report
Biotia Gets First-Ever NY State Regulatory Approval for a Urine Infectious Disease Test Powered by Genomics and AI
Read more
Report
Biotia, Pioneering Pathogen Detection Company, Raises an Oversubscribed $8M Series A
NEW YORK, NY / ACCESSWIRE / August 23, 2022 / Biotia, a company fighting infectious diseases powered by genomics and artificial intelligence (AI), has raised an oversubscribed $8 million Series A round
Read more
Report
Show more news